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Background: Hexokinase and glucokinase enzymes are ubiquitously expressed and use ATP and ADP as sub-
strates in mammalian systems and a variety of polyphosphate substrates and/or ATP in some eukaryotic and
microbial systems. Polyphosphate synthesising or utilizing enzymes are widely expressed in microbial systems
but have not been reported in mammalian systems, despite the presence of polyphosphate in mammalian cells.
Only two micro-organisms have previously been shown to express an enzyme that uses polyphosphate ex-
clusively.
Methods: A variety of experimental approaches, including NMR and NAD-linked assay systems were used to
conduct a biochemical investigation of polyphosphate dependent glucokinase activity in mammalian tissues.
Results: A novel mammalian glucokinase, highly responsive to hexametaphosphate (HMP) but not ATP or ADP
as a phosphoryl donor is present in the nuclei of mammalian hepatocytes. The liver enzyme exhibited sigmoidal
kinetics with respect to glucose with a S0.5 of 12 mM, similar to the known kinetics of mammalian ATP-glu-
cokinase. The Km for HMP (0.5 mM) was also similar to that of phosphoryl donors for mammalian ATP-glu-
cokinases. The new enzyme was inhibited by several nucleotide phosphates.
Conclusions: We report the discovery of a polyphosphate-dependent enzyme system in mammalian cells with
kinetics similar to established ATP-dependent glucokinase, also known to have a nuclear location. The kinetics
suggest possible regulatory or redox protective roles.
General significance: The role of polyphosphate in mammalian systems has remained an enigma for decades, and
the present report describes progress on the significance of this compound in intracellular metabolism in
mammals.
1. Introduction
Hexokinases are ubiquitously expressed and have a central role in
metabolism phosphorylating hexoses (e.g. glucose), raising the hexose
free-energy content and facilitating subsequent reactions central to
metabolic energy production and biosynthesis via NADPH production.
Hexokinases have undergone extensive evolution resulting in highly
specialized enzymes and isoenzymes that have distinct intracellular
location, substrate specificity and kinetics [1,2]. This has resulted in
highly specialized functions and accessory actions such as the key
components of the glucose sensor in the pancreas and brain [3,4]. The
majority of hexokinases studied use ATP exclusively as the phosphoryl
donor, though a novel mammalian hexokinase, expressed in rat and
man, with a different evolutionary origin uses ADP [5]. Many bacteria
and archaea also synthesise and use a variety of polyphosphate sub-
strates [6,7] which are considered evolutionary starting points for the
ATP-dependent enzymes. Polyphosphate chains may contain 1000 in-
organic phosphates joined by high energy phospho-anhydride bonds;
they are readily formed under high temperatures, or by dehydration of
inorganic phosphate, and would have been an available source of en-
ergy before ATP became ubiquitous [8]. Polyphosphate is present at
varying concentration in all mammalian cells studied, although no
enzymes have been identified to date responsible for either its synthesis
or utilization [9]. Two organisms, a phosphate accumulating bacterium,
Microlunatus phosphovorous [10] and a nitrogen-fixing cyanobacterium,
Anabaena sp. PCC 1720, express a hexokinase which exclusively uses
inorganic polyphosphate and, importantly, cannot phosphorylate
hexoses with ATP or ADP [11]. We now report on a mammalian
http://dx.doi.org/10.1016/j.bbrep.2017.09.004
Received 19 August 2017; Received in revised form 13 September 2017; Accepted 15 September 2017
⁎ Corresponding author.
E-mail address: s.p.burns@hud.ac.uk (S. Burns).
Abbreviations: HK, hexokinase; ATP-GK, glucokinase (mammalian ATP utilizing); PPGKm, polyphosphate dependent glucokinase (mammalian)
Biochemistry and Biophysics Reports 12 (2017) 151–157
Available online 20 September 2017
2405-5808/ © 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).
MARK
hexokinase which phosphorylates glucose exclusively using inorganic
polyphosphate, and which is inhibited by ATP. Inorganic polypho-
sphate is often concentrated in the hepatocyte nucleus [12], with a
variety of roles proposed, such as acting as a chaperone for nuclear
proteins, but until now it has not been shown to be of metabolic sig-
nificance [12]. The enzyme reported here is the first mammalian en-
zyme shown to utilize polyphosphate in a biochemical reaction. The
enzyme is expressed predominantly in the nucleus of hepatocytes, but is
also present in cardiac and striated muscle. Because of the enzyme's
kinetics we have named it polyphosphate dependent GlucoKinase,
mammalian, or PPGKm.
2. Methods
2.1. Tissue samples
Tissue samples were used immediately after being transported on
ice, or from frozen – no significant difference was found in activity or
kinetics from Hexokinase (HK), Glucokinase (GK) or polyphosphate
dependent glucokinase (PPGKm) using frozen tissue. Only tissues from
adult animals were studied: rat, ovine, bovine and porcine liver was
investigated for hexokinase activity as well as a variety of ovine tissues
including, heart, muscle, lung, kidney, spleen and adipose tissue. Local
and National procedures were followed using University Ethics com-
mittee approval for the use of animal tissues, and fulfilling the 2010/
63/EU directive and UK Home Office regulations.
2.1.1. Tissue homogenates
Tissue homogenates (10% w/v) were prepared in 50 mM HEPES
buffer containing 2.5 mM DTE, 7.5 mM MgCl2, 100 mM KCl, adjusted
to PH 7.4 and kept on ice or frozen at−80 °C. Homogenates were ultra-
centrifuged at 100,000 g in a Beckman Coulter ultra-centrifuge model
Ti 50,000 at 4 °C, and the supernatant removed and stored on ice or
frozen at −80 °C. For direct enzyme assay the supernatant was used
without modification. For separation procedures the supernatant was
then concentrated using Vivaspin® Centrifugal Concentrators at 4 °C
with a 30 kDa MW cut-off, and stored at−80 °C for further purification
steps (below).
2.2. NAD-linked hexokinase/glucokinase assay
Enzyme activity was determined as previously described exploiting
the well established difference in Km and S0.5 between hexokinases and
glucokinase respectively to obtain their activities. ATP, ADP, CTP, GTP
or HMP (sodium hexametaphosphate, 96% Sigma-Aldrich) were used at
5 mM where indicated (all reagents sourced from Sigma-Aldrich). In
previous work, the reaction blank for both HK and GK was the reaction
system without ATP using 0.5 and 100 mM glucose respectively.
Because of the native polyphosphate present in various tissues, the
blank for HK was used for the ‘GK’ and PPGKm assays - the rationale
being that if the enzyme under consideration is ATP dependent then the
concentration of glucose in the system should be irrelevant in the ab-
sence of ATP. The fact that increased activity was present in the absence
of ATP, but with increasing glucose concentration clearly indicates an
additional activity. This activity was lost when G6PDH was removed
from the system, on heating and on omission of magnesium. The section
on Nuclear Magnetic Resonance (NMR) identifies the mechanism of this
reaction. G6PDH from Leuconostoc mesenteroides (Sigma-Aldrich) was
used which uses NAD as a co-factor. All enzyme activity assays were
conducted in triplicate at 37 °C.
2.3. Purification steps and procedures
Precast Run Blue tris-glycine 4–12% gradient SDS-PAGE gels and
the relevant running and loading buffers were purchased from
Expedion Ltd. Spectra™ Multicolour Broad Range Ladders were
purchased from Life Technologies. The protein ladder was thawed at
room temperature, with 6 µl samples loaded directly into the first lane
of the gradient SDS-PAGE gel. All samples were mixed 1:4 with the
loading buffer, heated to 100 °C for 10 min and loaded onto the SDS-
PAGE gel. The samples were electrophoresed for 1 h at a 120v using an
XCell Surelock® Mini-Cell from Life Technologies at room temperature.
2.3.1. Chromatography
All enzyme purification steps were conducted with AKTA smart
FPLC system (GE Healthcare Life Sciences). Each step was examined for
separation suitability and fractions were further analysed for HK and
PPGKm activity. All columns were run at 1 ml/min with the exception
of the size exclusion column (0.5 ml/min) at room temperature.
2.3.1.1. Anion exchange chromatography. A strong anion exchange
media, Q HP, acquired as a pre-packed 1 ml column (GE Health care
Life Sciences), was equilibrated with 10 column volumes of buffer A
(50 mM HEPES, PH 7.4). Concentrated sheep liver extract (5 ml) was
injected onto the column at a rate of 1 ml/min. An initial wash step
with homogenization buffer was carried out for a further 5 ml, followed
by a gradient elution of protein fractions using the same buffer over
30 min.
2.3.1.2. Size exclusion chromatography. HiPrep 16/60 Sephacryl S-
200 h pre-packed gel filtration columns with a bed volume of 120 ml
were used. The columns were equilibrated with two column volumes of
homogenization buffer. A spin concentrated 500 µl sample was injected
into the column and automatic peak elution was set at 30 mAU running
for 8 h at 4 °C.
2.3.1.3. Hydrophobic interaction chromatography. HiTrap Butyl FF
prepacked Butyl Sepharose 4 Fast Flow columns were equilibrated
with 10 column volumes of buffer (3 M NaCl, 50 mM HEPES, PH 7.4).
The test samples were buffer exchanged with this buffer before loading
the column. An initial wash step with the same buffer was followed by
gradient elution of protein fractions with NaCl-free buffer (50 mM
HEPES, PH 7.4) over 30 min.
2.4. Substrate depletion on purified fractions
Supernatant was polyphosphate substrate depleted by incubation
with 100 mM glucose, 5 mM NAD and 8 units G6PDH in homogeniza-
tion buffer until activity tended to zero (approx.12 h at 37 °C). Addition
of 2 mM HMP restored activity.
2.5. Cell fractionation
Three buffers all adjusted to pH 7.4 were used in the cell fractio-
nation procedures as follows: Buffer 1 contained 0.25 M sucrose, 5 mM
Tris, 7.5 mM MgCl2 and 1 mM Dithiothreitol (DTT). Buffer 2 was
identical to Buffer 1 but contained 2 M sucrose instead of 0.25 M su-
crose. Buffer 3 contained 7.5 mM MgCl2, 2.5 mM DTT, 100 mM KCl
and 50 mM Na HEPES. Liver (10 g) was homogenized at 4 °C in 50 ml
Buffer 1 using a pestle and mortar for 10 min. The suspension was fil-
tered through muslin cloth and the homogenate spun in a 50 ml cen-
trifuge tube at 600 g for 10 min. The supernatant was retained (cyto-
plasmic fraction) and the pellet re-suspended (nuclear fraction) in 6 ml
of Buffer 2. The nuclear fraction was centrifuged at 800 g (Beckman
coulter Avanti J-26XPI centrifuge S/N JXT08C02) for 15 min. The su-
pernatant was discarded and the nuclear pellet re-suspended in Buffer I,
and kept on ice (nuclear fraction). The cytoplasmic fraction was spun at
8000 g (using Beckman coulter Avanti J-26XPI centrifuge S/N
JXT08C02) for 10 min: the supernatant was saved and the pellet re-
suspended (mitochondrial fraction) in 3 ml of homogenization Buffer I.
The remaining supernatant was then centrifuged at 15,000 g (Beckman
coulter Avanti J-26XPI centrifuge S/N JXT08C02) for 10 min, The
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pellet (lysosomal fraction) was re-suspended in 6 ml of homogenization
buffer 3, the final supernatant and the nuclear pellet were centrifuged
at 100,000 g for 1 h (using Beckman coulter optima L-look ultra-cen-
trifuge 52, Ti rotor S/N colo8E23). After the last spin, 3 × 1 ml aliquots
of particle-free supernatant were collected carefully avoiding the upper
fatty layer and stored at −80 °C and the pellet was re-suspended (mi-
crosomal fraction) in 3 ml of homogenization Buffer 3. The nuclear
pellet was re-suspended in 6 ml of Buffer 3.
The nuclear and the mitochondrial fractions were sonicated on ice
for a total of 20 s, at the highest speed with 5 s intervals to rupture the
nuclear and mitochondrial membranes and release the soluble proteins.
Then, both fractions were centrifuged at 4 °C for 30 min at 9000 g
(Beckman coulter Avanti J-26XPI centrifuge S/N JXT08C02) to remove
membrane debris. The supernatants were collected and the pellets
discarded. All aliquots were examined for PPGKm and hexokinase ac-
tivity as described above. All subcellular fractions were assayed for an
appropriate marker enzyme to ascertain their purity as previously de-
scribed [13] as follows: mitochondria, glutamate dehydrogenase; lyso-
somes, acid phosphatase; microsomes, glucose 6-phosphatase; particle
free supernatant, lactate dehydrogenase. Further details are available on
request to the corresponding author.
2.6. Protein identification by LC-MS/MS
In-gel digestion with trypsin was performed after reduction with
DTE and S-carbamidomethylation with iodoacetamide. Gel pieces were
washed two times with 50% (v:v) aqueous acetonitrile containing
aqueous 25 mM ammonium bicarbonate, then once with acetonitrile
before drying in a vacuum concentrator for 20 min. An 0.2 µg aliquot of
sequencing grade modified porcine trypsin (Promega) was added in
10 µl aqueous 25 mM ammonium bicarbonate prior to incubation
overnight at 37 °C.
Analysis was performed by LC-MS/MS following in-gel digestion
with trypsin. Peptides were eluted over a 20 min gradient using a
Waters nanoAcquity UPLC interfaced to a Bruker maXis HD mass
spectrometer. Peptide identification was achieved by searching tandem
mass spectra against the expected protein database using the Mascot
search program described below. Matches were filtered to accept only
peptides with expect scores of 0.005 or better. Protein inferences re-
quired a minimum of two unique peptide sequences.
Tandem mass spectra were searched against the Ovis subset of the
NCBI database (147,277 sequences; 77,737,218 residues) using a lo-
cally-running copy of the Mascot program (Matrix Science Ltd., version
2.5.1), through the Bruker ProteinScape interface (version 2.1). Search
criteria specified: Enzyme, trypsin; Fixed modifications,
Carbamidomethyl (C); Variable modifications, Oxidation (M),
Deamidation (N,Q); Peptide tolerance, 10 ppm; MS/MS tolerance,
0.1 Da; Instrument, ESI-QUAD-TOF.
2.7. Glucokinase NMR assays to establish the mechanisms of glucose
phosphorylation and its relationship to ATP-dependent glucokinase
NMR samples were run on a Bruker Avance 500 NMR Spectrometer
using a 5 mm Broadband BBO probe with z-gradients and ATMA (au-
totune and match). NMR 5 mm tubes were loaded with 600 µl of
homogenate and 20 iu of G6PDH, 99% 13C1-glucose, 2 mM HMP or
5 mM ATP in homogenizing buffer were added as required.
Experiments were started with the addition of glucose or G6PDH de-
pending on the experimental requirements. The increased volume of
homogenate, and hence enzyme was necessary to account for the lower
sensitivity of the 31P NMR assay. The reactions were monitored over
4 h. 13C and 31P NMR spectra were recorded in an interleaved fashion
such that blocks of data could be merged with comparable time stamps
for comparison. Spectra were recorded fully relaxed using 30° pulses
and a 5 s recycling time to satisfy quantitative requirements. 13C and
31P spectra were acquired proton decoupled to maximise sensitivity.
3. Results and discussion
3.1. Polyphosphate dependent glucose 6-phosphorylating activity in liver
Whilst investigating the adaptions of liver function during preg-
nancy we observed a very high activity of hexokinase in bovine and
ovine tissue extracts which was ATP-independent and only present at
high concentrations of glucose (above 10 mM). Following the discovery
of a mammalian ADP-dependent hexokinase [5] we decided to screen
tissues for enzyme activity with ADP and a variety of phosphorylation
substrates, using a standard glucokinase (GK) assay protocol [14,15]
but accounting for the ATP-independent activity which had previously
been mistakenly used as a blank in the GK assay [16]. Since inherent
activity of the enzyme might arise from native polyphosphates already
in the liver [17], we included inorganic polyphosphates in this screen.
The liver enzyme was shown to be highly responsive to inorganic
polyphosphate, particularly hexametaphosphate (Fig. 1).
The enzyme showed significant inhibition by ATP and other nu-
cleotides (Fig. 1) Addition of 5 mM ATP, ADP or AMP had similar ef-
fects on lowering activity (P<0.01) suggesting the nucleoside moiety
itself was responsible for lowering activity. Qualitatively similar data
were obtained from other species (Fig. 3C) with the highest activity in
ovine liver and lowest in rat liver. The majority of known polypho-
sphate dependent hexokinases are also capable of using ATP as a sub-
strate. However, only two organisms have been reported to express
hexokinase enzymes that use polyphosphate exclusively as a substrate
[10,11]. The structural basis of restricting the active site to polypho-
sphate, and preventing ATP utilization is currently unknown, and sig-
nificant homology between the exclusive and inclusive polyphosphate
and ATP utilizing enzymes raises the question of how this is achieved.
Mammalian hexokinase isozymes 1–3 (HK1-3) are allosterically in-
hibited by the product, glucose 6-phosphate [2]. Nucleoside phosphate
sensitive allosteric sites are common on metabolically regulated en-
zymes conferring, for example, cellular energy charge [2], but the
precise role of nucleoside sensitivity in the new enzyme merits further
study.
3.2. Kinetics of the ATP independent polyphosphate dependent glucokinase
Mammalian ATP-dependent glucokinase does not follow Michaelis-
Menten kinetics, but shows a sigmoidal response to glucose. Km, the
half-saturating substrate concentration which indicates substrate
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Fig. 1. Glucose 6-phosphorylating activity of a novel polyphosphate dependent glucoki-
nase in mammalian liver using different phosphorylation substrates. Results are
mean± sem (n = 3 replicates) with * indicating p< 0.05, and **p<0.01. Data shown
are from ovine liver. In the absence of ATP the enzyme was capable of utilizing an in-
herent bound polyphosphate (NPP) substrate to covert glucose to glucose 6-phosphate.
ATP and other nucleoside phosphates (5 mM) inhibited the enzyme, whilst 5 mM in-
organic polyphosphate as hexametaphosphate (HMP) resulted in markedly increased
activity. Significant differences indicated to NPP. 1 international enzyme unit (IU) =
1.0 µmol G6P formed per min per g liver.
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affinity for a Michaelis-Menten enzyme is replaced with the analogous
S0.5 for a sigmoidal enzyme. There was a sigmoidal response to in-
creasing glucose concentration and high half-saturating glucose kinetics
(S0.5 for glucose = 12 mM) (Fig. 2A) for the polyphosphate dependent
glucokinase. The low affinity for glucose is similar to mammalian ATP-
dependent glucokinase (hexokinase type 4, commonly referred to as
glucokinase or GK) which also shows a sigmoidal response to glucose as
a monomeric enzyme with an S0.5 of 8 mM. These two features, in-
hibition and sigmoidal kinetics with respect to glucose might indicate
strong similarity to mammalian glucokinase [18–20]. Polyphosphate
entry to the active site has been proposed to arise via a sequential
mechanism (11) but evidence is presented in this study that polypho-
sphate is already tightly bound to the enzyme (see 3.4. below). The
kinetics with respect to polyphosphate (Fig. 2B) suggest that the en-
zyme may be responsive to local, possibly bound polyphosphate, as the
Km is similar to that of mammalian hexokinases Km for ATP and higher
(500 μM) than that reported in microbial systems (2 μM – Ref. [11]).
3.3. Subcellular, tissue and species distribution of PPGKm
The inhibition of PPGKm by ATP suggested an alternative bio-
chemical mechanism to GK, which involves an inhibitory regulatory
protein (GKRP), so we next investigated the subcellular distribution of
enzyme activity in liver. Mammalian GK resides in the hepatocyte nu-
cleus during fasting and its activation and release from an inhibitory
binding protein leads to cytosolic translocation and phosphorylation of
glucose in the cytoplasm [20]. The high S0.5 and low glucose affinity of
ATP-GK ensures that enzyme activity increases in line with glycemia
and metabolism of glucose during feeding. These kinetic properties give
the enzyme key roles in the brain, liver and pancreas [20]. The low
affinity for glucose of the novel polyphosphate dependent enzyme de-
scribed here would confer a similar capacity on PPGKm and its total
cellular activity is of the same order. Cell fractionation studies showed
that the enzyme was highly concentrated in the hepatocyte nucleus
(Fig. 3A). During fasting ATP-GK is known to accumulate in the hepa-
tocyte nucleus, but does not normally phosphorylate glucose there [21].
Activity of ATP-GK is not found outside of the liver, pancreatic ß-cell
and brain: in contrast PPGKm was present in striated muscle and was
also found at a significant concentration in cardiac tissue and lung
(Fig. 3B). Activity was very low in adipose tissue and kidney, and un-
measurable in spleen. A preliminary investigation into the species wide
distribution of PPGKm activity indicated that it was at high activity in
ovine, bovine and porcine liver (Fig. 3C). Activity was also present in
sufficient quantities in rat liver to warrant a re-appraisal of hexokinase
measurements in this species, since the presence of polyphosphate-
dependent high Km (S0.5) enzymes would interfere with existing HK/GK
measurement techniques and strategies, particularly in the liver.
3.4. Partial purification suggests molecular characteristics distinct from
existing hexokinases
Gel filtration (Fig. 4(A) and (B)) indicated that PPGKm has a higher
molecular weight (Mw) than hexokinases I-III with ‘fraction 3 and 4’
displaying a high activity of PPGKm but no low Km hexokinase activity.
PPGKm exhibited a larger range of molecular weights (fractions 4–12)
than the low Km hexokinases (fractions 5–11). Gel filtration of the
nuclear fraction obtained from cell fractionation (Fig. 4A) reinforced
this conclusion and also indicated a broader molecular weight profile,
with no low Km hexokinases detected. We postulated that a varied chain
length of the polyphosphate substrate tightly bound to the PPGKm
might account for this Mw variation. To investigate this, further se-
paration procedures were conducted using anionic exchange, hydro-
phobic column chromatography and SDS-PAGE (Fig. 3C). As activity
was retained at every stage of separation we decided to substrate de-
plete the partially purified enzyme of polyphosphate and re-analyze
with PAGE (Fig. 3C). The substrate depleted enzyme showed no activity
in the presence of 100 mM glucose, but activity was readily restored by
the addition of HMP (data not shown).
During the process of partial purification two principle bands were
visible in the fraction with enzyme activity (Fig. 4C lane 4) at ap-
proximately 55 kDa and 110 kDa (arrows A and B), possibly suggesting
that the enzyme can dimerize like HKs, but can also function as a
monomer following substrate depletion (lane 5). These results may help
explain the molecular weight range observed in gel filtration compared
with HK1-3 (Fig. 2A and B). The appearance of a new lower molecular
weight band following substrate depletion (lane 5, arrow B) may be the
result of the tightly bound polyphosphate being lost during the process
of substrate exhaustion, resulting in an enzyme with an apparent mo-
lecular weight lowered by a few kDa. Each kDa of molecular weight is
equivalent to 10 orthophosphate moieties lost from the enzyme during
substrate depletion. An alternative interpretation is that the structure of
the protein is altered during substrate depletion resulting in a structure
or amino acid residue driven gel shift. Unexplained gel shifts of proteins
with known molecular weights and structures has highlighted the role
of specific domains and residues [22] as well as post-translational
modification significantly influencing the extent of SDS-binding and
causing characteristic, predictable SDS-PAGE gel shits [23]. Tight
polyphosphate binding could result in gel shifts if it is retained during
SDS treatment in this way. Following substrate depletion, PPGKm ac-
tivity could be readily restored by the addition of 2 mM HMP to the
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Fig. 2. Enzyme kinetics with respect to (A) glucose and (B) polyphosphate Results are mean± sem (n = 3 replicates). PPGKm displayed sigmoidal kinetics with respect to glucose (A),
with a high S0.5 of 12 mM, making it a true glucokinase potentially sensitive to physiological glucose concentrations. The Vmax of the enzyme and its phosphorylating capacity are in the
same order as human and rat glucokinase in liver. Sigmoidal fit using SigmaPlot's enzyme kinetics module. (B) An inverse plot of 1/v (enzyme velocity versus 1/s (substrate - hex-
ametaphosphate concentration with glucose constant at 10 mM). Classical Michaelis-Menten kinetics for HMP gave a Km of 0.5 mM, comparable to the Km for ATP of that of mammalian
ATP-GK.
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assay system, indicating that the enzyme was functioning normally but
that the bound polyphosphate had been exhausted, or chain-shortened
such that it was inaccessible to the active site. The progressive appli-
cation of chromatographic techniques revealed several biochemical and
biophysical properties of PPGKm. Elution on an anionic column in-
dicated that the enzyme was highly negatively charged, possibly as a
result of tight polyphosphate binding. The enzyme showed very little
interaction with a hydrophobic column suggesting it has no major ex-
posed hydrophobic domains. Gel filtration indicated that the polypho-
sphate dependent glucokinase was larger than HK1-3, with bands in the
SDS-PAGE gel suggesting a dimer with a Mw of 110 kDa. Substrate
depletion indicated that polyphosphate may account for a significant
proportion of the molecular weight and that it may not bind equally to
both polypeptide chains.
3.5. NMR based enzyme assays define the glucose 6-phosphorylation
mechanism of PPGKm
Using 31P NMR it was possible to show that PPGKm metabolized
HMP in a similar way to its ATP dependent analogues GK and HK
metabolizing ATP (Fig. 5). In the absence of G6PDH, the linking enzyme
in the NADH assay, little G6P was formed even after 3 h (Fig. 5). This
occurred at a similar rate to HK but slower than GK, suggesting negative
feedback by G6P, a classical feature of the dimeric low Km HKs [2]. On
addition of G6PDH large amounts of 6-phosphogluconate (6PG) were
formed as expected in both ATP and HMP driven reactions. In the HMP
assay, ATP was absent so the formation of phosphorylated glucose
moieties (G6P and 6-phosphogluconate – 6PG) must have arisen from
HMP derived orthophosphate moieties. This was reinforced in the 13C
spectra (Fig. 5b): the glucose used in the experiment was labelled with
99% 13C at C1, so the appearance of the peak at 178.5 ppm confirms
that the aldehyde group C1 had been oxidised to a carboxylic acid with
a concomitant chemical shift in the NMR spectrum from 97 and 99 ppm
(alpha and beta anomers at C1 in glucose) – i.e. the conversion of
glucose to gluconate. The chemical shift of the 6PG peak was confirmed
in the samples by spiking them with known standards, and PPGKm
produced identical results to hepatic ATP dependent GK, when 100 mM
glucose and 5 mM ATP were used in the absence of HMP. These results
reinforced the conclusion that the enzyme mechanism conducted by
PPGKm and ATP-GK are similar, both producing G6P from glucose, but
that PPGKm is a polyphosphate dependent glucose 6-phospho-
transferase.
The partial purification procedure shown in Fig. 4C was used to
obtain LC-MS/MS fingerprinting on two occasions at two separate
stages. The bands in Lane 5 indicated homology only to catalase. Fol-
lowing gel filtration and SDS-PAGE of the nuclear fraction derived from
the cell fractionation studies, the band at 110 kDa was fingerprinted
with MS/MS. This indicated the presence of a number of proteins but no
established HK or GK protein homology was identified. HK homology in
this band was to that of HSP70 (A1/B1) which has an ATP/ADP binding
site and a nuclear localization. HSP70 is known to bind polyphosphate
[12] but recombinant HSP70 did not show PPGK activity in the pre-
sence or absence of HMP (including after overnight incubation with
2 mM HMP – Ali et al. unpublished data). Whether post-translational
modification or complexing of HSP70 results in the activity described is
currently unknown.
3.6. Substrate specificity of the hexokinase active site
It is likely that polyphosphate was an early phosphorylation sub-
strate during the emergence of life before ATP synthesis became
widespread [8]. It was present in all the mammalian cells studied and
has been shown to be critical in a number of cellular processes, such as
the activation of mTOR, demonstrated in mammary cancer cells [24].
Identification of the PPGKm gene is a critical next step in understanding
the role of this enzyme in mammalian cells. One fundamental question
Fig. 3. The polyphosphate dependent glucokianse retained its native substrate in the nucleus (A) of the hepatocyte, but remained highly responsive to exogenous HMP. PF = Particle-Free
supernatant. Tissue (A) and (B) species distribution suggest widespread expression consistent with long standing observations of polyphosphate presence in mammalian cells. In the tissue
and species (C) studied PPGKm remained responsive to external HMP indicated by asterisks, but also showed some native activity (NPP).
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is how the active sites of hexokinases are organised to accept either ATP
and/or polyphosphates, especially those that use ATP alone or poly-
phosphate alone. An understanding of how ATP can be specifically
excluded as a substrate may help in understanding hexokinase evolu-
tion and early phospho-anhydride biochemistry. Inhibition of hex-
okinases is of interest in cancer research and the specificity of inhibitors
with respect to ATP, ADP or polyphosphates amongst the hexokinase
family may help to inform inhibitor design and emerging strategies in
cancer hexokinase inhibitor therapeutics [25].
4. Conclusions
A third example of a hexokinase using polyphosphate exclusively as
a phosphoryl donor has been identified, this time in mammalian tissues.
This is the first polyphosphate utilizing enzyme activity demonstrated
in mammalian cells as far as we are aware. The evolutionary sig-
nificance of this enzyme may help in the understanding of the shift of
substrate specificity of hexokinases from polyphosphate to ATP. The
enzyme kinetics are similar to glucokinase as defined by its high S0.5 for
glucose. Preliminary analysis suggests that the enzyme tightly binds
polyphosphate which can act as a native substrate for glucose 6-phos-
phorylation. Because of the finite supply of polyphosphate in cells, the
enzyme system is likely to be involved in acute cellular events. An
obvious possibility, though speculative, is the supply of increased re-
ductive capacity in the form of NADPH for glutathione synthesis during
oxidative stress, supported by the observation that G6PDH localizes to
the nuclear periphery [26].
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Fig. 5. (A) 31P NMR and (B) 13C NMR spectra acquired during the HMP assay of PPGKm in the presence and absence of the linking enzyme G6PDH and 100 mM glucose labelled 99% 13C
at carbon 1. G6P formation occurred slowly in the absence of G6PDH. In the absence of G6PDH 6-phosphogluconate was below detection with 13C NMR, but, on addition of G6PDH rapid
oxidation of the C1 of glucose 6-phosphate occurred, producing the carboxylic acid group of 6-phosphogluconate at C1. Similar results were obtained using recombinant glucokinase. 6PG
was only formed at 100 mM glucose and not at 0.5 mM glucose. These data confirm that the enzyme mechanism involves the same intermediates and follows the same biochemical
mechanism for ATP-GK and PPGKm except that the latter only uses PolyPi and not ATP to achieve glucose 6-phosphorylation in the presence of 100 mM glucose.
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